Axogen (AXGN) Gains from Investment Securities (2011 - 2026)
Axogen (AXGN) recorded quarterly Gains from Investment Securities of $7000.0 in Q1 2026, up 163.64% quarter-over-quarter from -$11000.0 in Q4 2025, and up 600.0% on a YoY basis from $1000.0 in Q1 2025.
Axogen (AXGN) Gains from Investment Securities (2011 - 2026) Analysis & Trends
Axogen's Gains from Investment Securities history runs 16 years deep, the most recent figure standing at $7000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 600.0% year-over-year to $7000.0; the TTM figure through Mar 2026 stood at $6000.0 (up 400.0% YoY), while the FY2023 annual figure was $10000.0, down 16.67% from the prior year.
- Gains from Investment Securities was $7000.0 for Q1 2026 at Axogen, up from -$11000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $11000.0 in Q2 2023 to a low of -$11000.0 in Q4 2025.
- Historically, Gains from Investment Securities has averaged $1705.9 across 5 years, with a median of $2000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities soared 1200.0% in 2023, then sank 300.0% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then tumbled by 300.0% to -$6000.0 in 2024, then sank by 83.33% to -$11000.0 in 2025, then soared by 163.64% to $7000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $7000.0 (Q1 2026), -$11000.0 (Q4 2025), and $3000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |